Details

SARS-CoV-2 structural proteins affect the expression of IL-8 and TNF-α cytokines and APOBEC genes in human lung A549 and liver Huh-7 cells
ID Bergant Marušič, Martina (Author), ID Caetano Costa, Margarida (Author), ID Turk, Špela (Author), ID Lovšin, Nika (Author)

URLURL - Source URL, Visit https://acta.pharmaceutica.farmaceut.org/wp-content/uploads/2025/06/29925.pdf This link opens in a new window

Abstract
The apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC) proteins belong to a family of cytidine deaminases responsible for DNA and RNA sequence editing, playing pivotal roles in a wide range of biological processes, including immune responses, antiviral properties, and genetic mutations. In this work, we investigated the effect of SARS-CoV-2 structural proteins – Envelope (E), Spike (S), Nucleocapsid (N), Membrane (M) and protein ORF6 – on the expression of cytokines Interleukin 8 (IL-8) and Tumor Necrosis Factor-alpha (TNF-α), and APOBEC3s proteins (APOBEC3B and APOBEC3F) genes in Huh-7 and A549 human cell lines. While there is plenty of scientific evidence about the effects of SARS-CoV-2 on the inflammatory cascade, the current literature regarding the impact of SARS-CoV-2 on APOBEC expression is scarce. Our findings reveal a complex relationship between SARS-CoV-2 structural proteins and the host immune response, as certain viral structural proteins (S, M, E) modulate cytokine expression, potentially contributing to the dysregulated immune responses seen in COVID-19 patients. Additionally, our research uncovered interactions between viral proteins and APOBEC genes. This study contributes to a better understanding of the host-virus interactions in the context of SARS-CoV-2 infection and provides some insights into potential therapeutic targets for mitigating the immunopathological consequences of the disease.

Language:English
Keywords:APOBEC, nucleocapsid, spike protein, envelope protein, A3B, A3F, IL-8, TNF-α
Typology:1.03 - Other scientific articles
Organization:FFA - Faculty of Pharmacy
Publication version:Version of Record
Publication date:01.01.2025
Year:2025
Number of pages:Str. 283-297
Numbering:Vol. 75, iss. 2
PID:20.500.12556/RUL-169969 This link opens in a new window
UDC:578.834
ISSN on article:1846-9558
COBISS.SI-ID:240683011 This link opens in a new window
Publication date in RUL:30.06.2025
Views:824
Downloads:173
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Acta pharmaceutica
Shortened title:Acta pharm.
Publisher:Croatian Pharmaceutical Society
ISSN:1846-9558
COBISS.SI-ID:3817585 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:APOBEC, nukleokapsida, koničasti protein, ovojnični protein, A3B, A3F, IL-8, TNF-α

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-2518-2020
Name:Proteini APOBEC in onkogeneza virusov HPV

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0034-2020
Name:Analitika in kemijska karakterizacija materialov ter procesov

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127-2019
Name:Farmacevtska biotehnologija: znanost za zdravje

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back